Do dopaminergic agents increase the daytime sleep propensity? Article reviewed: Effect of ropinirole on sleep onset. A randomized, placebo-controlled study in healthy volunteers

Sleep Medicine

Volumn 3, Issue 5, 2002, Pages 445-446

  Zucconi, Marco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; ROPINIROLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NIGHT SLEEP; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SLEEP; SOMNOLENCE; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 0036749960     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(02)00104-1     Document Type: Note

References (10)

1. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58:341-346.
2. Wisor J, Nishino S, Sera I, Uhl GH, et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001;21:1787-1794.
3. Lagos P, Scorza C, Monti JM, Santos H, et al. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking locomotor activity and striatal dopamine release in rats. Ear Neuropsychoparmacol 1998;8:113-120.
4. Piercey MF, Camacho-Ochoa M, Smith MW. Functional roles of dopamine-receptor subtypes. Clin Neuropharmacol 1995;18:34-42.
5. Monti JM, Hawkins M, James H, D'Angelo L, Fernandez M. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 1988;95(3):395-400.
6. Ongini E, Caporali MG. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behavior in the rabbit. Neuropharmacology 1987;26:355-360.
7. Saletu B, Gruber G, Saletu M, Brandstatter N, et al. Sleep laboratory studies in Restless Legs Syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 2000;41:181-189.
8. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole. A double-blind-randomized trial. Neurology 1999;52:938-943.
9. Bassetti C, Clavadetscher S, Gugger M, Hess CW. Pergolide-associated 'sleep attacks' in a patient with restless legs syndrome. Sleep Med 2002;3:275-277.
10. Hobson DE, Lang AE, Martin WRW, Razmy A, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian Movements Disorders Group. J Am Med Assoc 2002;287:455-463.